Josiah Craver - 17 Sep 2024 Form 3 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Principal Financial Officer
Signature
/s/ John Celebi, Attorney-in-Fact
Issuer symbol
SNSE
Transactions as of
17 Sep 2024
Net transactions value
$0
Form type
3
Filing time
26 Sep 2024, 16:36:21 UTC
Next filing
23 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SNSE Stock Option (Right to Buy) 17 Sep 2024 Common Stock 80,000 $0.6600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on July 22, 2025, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Remarks:

Exhibit 24 - Power of Attorney